Medtronic plc

NYSE-MDT

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Apr '15	Apr '16	Apr '17	Apr '18	Apr '19	Apr '20	Apr '21	Apr '22	Apr '23	Apr '24	LTM
Total Revenues						28,913	30,117	31,686	31,227	32,364	32,577
Total Revenues % Chg.						-5.4%	4.2%	5.2%	-1.4%	3.6%	3.2%
Cost of Goods Sold, Total						9,269	10,355	10,028	10,622	11,091	11,231
Gross Profit						19,644	19,762	21,658	20,605	21,273	21,346
Selling General & Admin Expenses, Total						9,882	9,956	10,047	10,004	10,183	10,243
R&D Expenses						2,331	2,493	2,746	2,696	2,735	2,743
Amortization of Goodwill and Intangible Assets						1,756	1,783	1,733	1,698	1,693	1,678
Other Operating Expenses						513	40	285	429	253	306
Other Operating Expenses, Total						14,482	14,272	14,811	14,827	14,864	14,970
Operating Income						5,162	5,490	6,847	5,778	6,409	6,376
Interest Expense, Total						-1,092	-925	-553	-583	-719	-738
Interest And Investment Income				—	—	—	—	186	386	597	598
Net Interest Expenses						-1,092	-925	-367	-197	-122	-140
Currency Exchange Gains (Loss)						477	-230	198	672	176	168
Other Non Operating Income (Expenses)	—	—				310	340	36	68	-293	-294
EBT, Excl. Unusual Items						4,857	4,675	6,714	6,321	6,170	6,110
Restructuring Charges						-441	-617	-1,110	-645	-828	-798
Merger & Related Restructuring Charges					—	—	—	—	-233	-338	-338
Impairment of Goodwill	—	—	—	—	—	—	—	—	-61	—	—
Gain (Loss) On Sale Of Investments						-13	—	8	56	—	81
Gain (Loss) On Sale Of Assets	—	—	—		—	—	—	—	-75	—	—
Asset Writedown	—	—	—	—	—	-10	—	—	—	—	—
In Process R&D Expenses	—	—	—	—		-25	-45	—	—	—	—
Legal Settlements						-313	-118	-95	30	-149	-190
Other Unusual Items		—		—		—	—	—	-29	-18	43
EBT, Incl. Unusual Items						4,055	3,895	5,517	5,364	4,837	4,908
Income Tax Expense						-751	265	456	1,580	1,133	953
Earnings From Continuing Operations						4,806	3,630	5,061	3,784	3,704	3,955
Minority Interest	—	—				-17	-24	-22	-26	-28	-28
Net Income						4,789	3,606	5,039	3,758	3,676	3,927
Net Income to Common Incl Extra Items						4,789	3,606	5,039	3,758	3,676	3,927
Net Income to Common Excl. Extra Items						4,789	3,606	5,039	3,758	3,676	3,927
Total Shares Outstanding						1,341.1	1,345.4	1,330.7	1,330.8	1,311.3	1,282.5
Weighted Avg. Shares Outstanding						1,340.7	1,344.9	1,342.4	1,329.8	1,327.7	1,318.4
Weighted Avg. Shares Outstanding Dil						1,351.1	1,354	1,351.4	1,332.8	1,330.2	1,320.9
EPS						3.6	2.7	3.8	2.8	2.8	3
EPS Diluted						3.5	2.7	3.7	2.8	2.8	3
EBITDA						7,825	8,192	9,554	8,475	9,056	9,013
Effective Tax Rate						-18.5%	6.8%	8.3%	29.5%	23.4%	19.4%